Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Mayo Clinic
German CLL Study Group
Karolinska University Hospital
Columbia University
University Health Network, Toronto
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH